GL1X · GenesisL1 explorer

MolNFT v1 · #151019 · protein

Crystal structure of the bromodomain of human SMARCA2 in complex with smarca-bd ligand

6HAZ · Probable global transcription activator SNF2L2: “Crystal structure of the bromodomain of human SMARCA2 in complex with smarca-bd ligand”. X-ray diffraction, 2 ligands (FX5, ZN), 2 pockets (best druggability 0.68). MolNFT v1 #151019…

PDB
6HAZ
Type
protein
Length
226 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable global transcription activator SNF2L2
EC
3.6.4.-
UniProt
P51531
Ligands
FX5, ZN
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProbable global transcription activator SNF2L2 (EC 3.6.4.-)protein11365% helix, 2% strandP51531

Ligands and binding sites

  • FX5 · 2-(6-azanyl-5-piperazin-4-ium-1-yl-pyridazin-3-yl) phenol · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14810.680.7955FX5
2680.500.8416FX5

Interfaces

1 interface between chains.

  • A–B · 586 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 6HAZ · Crystal structure of the bromodomain of human SMARCA2 in complex with SMARCA-BD ligand · the same entry in another collection · chain A against A, TM-score 1.00
  • P51531 · AlphaFold monomer V2.0 prediction for probable global transcription activator SNF2L2… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.